Chemical targeting of NEET proteins reveals their function in mitochondrial morphodynamics.

NEET proteins contact sites mitochondria morphodynamics virus

Journal

EMBO reports
ISSN: 1469-3178
Titre abrégé: EMBO Rep
Pays: England
ID NLM: 100963049

Informations de publication

Date de publication:
03 12 2020
Historique:
received: 07 08 2019
revised: 24 09 2020
accepted: 08 10 2020
pubmed: 13 11 2020
medline: 28 4 2021
entrez: 12 11 2020
Statut: ppublish

Résumé

Several human pathologies including neurological, cardiac, infectious, cancerous, and metabolic diseases have been associated with altered mitochondria morphodynamics. Here, we identify a small organic molecule, which we named Mito-C. Mito-C is targeted to mitochondria and rapidly provokes mitochondrial network fragmentation. Biochemical analyses reveal that Mito-C is a member of a new class of heterocyclic compounds that target the NEET protein family, previously reported to regulate mitochondrial iron and ROS homeostasis. One of the NEET proteins, NAF-1, is identified as an important regulator of mitochondria morphodynamics that facilitates recruitment of DRP1 to the ER-mitochondria interface. Consistent with the observation that certain viruses modulate mitochondrial morphogenesis as a necessary part of their replication cycle, Mito-C counteracts dengue virus-induced mitochondrial network hyperfusion and represses viral replication. The newly identified chemical class including Mito-C is of therapeutic relevance for pathologies where altered mitochondria dynamics is part of disease etiology and NEET proteins are highlighted as important therapeutic targets in anti-viral research.

Identifiants

pubmed: 33180995
doi: 10.15252/embr.201949019
pmc: PMC7726809
doi:

Substances chimiques

Mitochondrial Proteins 0
Iron E1UOL152H7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e49019

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 16CONV30UPDE
Organisme : Agence Nationale de la Recherche
ID : ANR0015TD
Organisme : Deutsche Forschungsgemeinschaft
ID : U1151SE19KA
Organisme : United States - Israel Binational Science Foundation (BSF)
ID : BSF 2015831
Organisme : Deutsche Forschungsgemeinschaft
ID : 2015831
Organisme : Intramural NIH HHS
ID : Z01 NR000015
Pays : United States
Organisme : Deutsche Forschungsgemeinschaft
ID : 240245660
Organisme : Deutsche Forschungsgemeinschaft
ID : L17V22CONV02
Organisme : Deutsche Forschungsgemeinschaft
ID : U115120K
Organisme : Inserm | Inserm Transfert (Inserm Transfert SA)
ID : ATIP-Avenir
Organisme : Université de Paris
ID : Université de Paris L17V22CONV02
Organisme : Université de Paris
ID : Université de Paris 16CONV30UPDE
Organisme : Deutsche Forschungsgemeinschaft (DFG)
ID : 240245660 SFB 1129TP13

Informations de copyright

© 2020 The Authors.

Références

Physiol Rev. 2009 Jul;89(3):799-845
pubmed: 19584314
Nat Rev Mol Cell Biol. 2020 Apr;21(4):204-224
pubmed: 32071438
EMBO Mol Med. 2013 Jun;5(6):904-18
pubmed: 23703906
J Immunol. 2014 Sep 15;193(6):3080-9
pubmed: 25135833
Biochem Biophys Res Commun. 2017 Feb 19;483(4):1069-1077
pubmed: 27485547
Antioxid Redox Signal. 2019 Mar 10;30(8):1083-1095
pubmed: 29463105
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14676-81
pubmed: 23959881
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5318-23
pubmed: 17376863
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13047-52
pubmed: 21788481
Front Cell Infect Microbiol. 2019 Apr 18;9:95
pubmed: 31058096
J Transl Med. 2019 Jul 23;17(1):238
pubmed: 31337416
Assay Drug Dev Technol. 2007 Jun;5(3):381-90
pubmed: 17638538
Hum Mol Genet. 2017 May 1;26(9):1599-1611
pubmed: 28335035
Curr Biol. 2017 Feb 6;27(3):371-385
pubmed: 28132811
Neurochem Int. 2017 Oct;109:171-183
pubmed: 28389271
EMBO J. 2010 Feb 3;29(3):606-18
pubmed: 20010695
Cell. 2014 Nov 20;159(5):1027-1041
pubmed: 25416943
J Mol Endocrinol. 2017 Feb;58(2):R87-R106
pubmed: 27965371
Biochim Biophys Acta. 2015 Jun;1853(6):1294-315
pubmed: 25448035
mBio. 2017 Jan 10;8(1):
pubmed: 28074025
Biochim Biophys Acta Mol Cell Res. 2019 Apr;1866(4):650-662
pubmed: 30668969
Int J Mol Sci. 2018 Feb 13;19(2):
pubmed: 29438347
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):272-277
pubmed: 29259115
J Mol Biol. 2009 Sep 11;392(1):143-53
pubmed: 19580816
J Cell Biol. 1998 Oct 19;143(2):351-8
pubmed: 9786947
EMBO Rep. 2010 Feb;11(2):133-8
pubmed: 20019757
Cancer Res. 2004 Feb 1;64(3):985-93
pubmed: 14871829
J Biol Chem. 2017 Jun 16;292(24):10061-10067
pubmed: 28461337
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8277-8282
pubmed: 28716905
Am J Hum Genet. 2007 Oct;81(4):673-83
pubmed: 17846994
Essays Biochem. 2018 Jul 20;62(3):341-360
pubmed: 30030364
J Biol Inorg Chem. 2018 Jun;23(4):599-612
pubmed: 29435647
Nature. 2013 Mar 21;495(7441):389-93
pubmed: 23455425
Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14590-5
pubmed: 21844353
PLoS Pathog. 2013;9(12):e1003722
pubmed: 24339771
FEBS J. 2014 Jul;281(14):3095-112
pubmed: 24841215
EMBO Rep. 2020 Dec 3;21(12):e49019
pubmed: 33180995
Cell Host Microbe. 2016 Sep 14;20(3):342-356
pubmed: 27545046
Genes Dev. 2009 May 15;23(10):1183-94
pubmed: 19451219
J Biol Chem. 2007 Apr 13;282(15):11521-9
pubmed: 17301055
Biochim Biophys Acta. 2013 Nov;1833(11):2526-41
pubmed: 23380708
Neurobiol Dis. 2016 Feb;86:154-69
pubmed: 26611103
Nat Rev Mol Cell Biol. 2012 Dec;13(12):780-8
pubmed: 23175281
Science. 2011 Oct 21;334(6054):358-62
pubmed: 21885730
J Cell Sci. 2016 Jun 15;129(12):2297-306
pubmed: 27189080
J Biol Chem. 2006 Dec 8;281(49):37972-9
pubmed: 17003040
J Cell Biol. 2014 Mar 17;204(6):919-29
pubmed: 24616225

Auteurs

Diana Molino (D)

Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris, Paris, France.

Irene Pila-Castellanos (I)

Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris, Paris, France.
ENYO-Pharma, Lyon, France.

Henri-Baptiste Marjault (HB)

The Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Jerusalem, Israel.

Nivea Dias Amoedo (N)

Cellomet, Genomic Functional Center, Bordeaux, France.

Katja Kopp (K)

Department of Infectious Diseases, Molecular Virology, Centre for Integrative Infectious Disease Research (CIID), University of Heidelberg, Heidelberg, Germany.

Leila Rochin (L)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Sud University, Saclay University, Paris, Gif-sur-Yvette, France.

Ola Karmi (O)

The Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Jerusalem, Israel.

Yang-Sung Sohn (YS)

The Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Jerusalem, Israel.

Laetitia Lines (L)

ENYO-Pharma, Lyon, France.

Ahmed Hamaï (A)

Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris, Paris, France.

Stéphane Joly (S)

ENYO-Pharma, Lyon, France.

Pauline Radreau (P)

ENYO-Pharma, Lyon, France.

Jacky Vonderscher (J)

ENYO-Pharma, Lyon, France.

Patrice Codogno (P)

Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris, Paris, France.

Francesca Giordano (F)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Sud University, Saclay University, Paris, Gif-sur-Yvette, France.

Peter Machin (P)

ENYO-Pharma, Lyon, France.

Rodrigue Rossignol (R)

Cellomet, Genomic Functional Center, Bordeaux, France.
Maladies Rares: Génétique et Métabolisme (MRGM), INSERM U1211, Bordeaux, France.

Eric Meldrum (E)

ENYO-Pharma, Lyon, France.

Damien Arnoult (D)

Institut André Lwoff, INSERM UMRS1197, Hôpital Paul Brousse, Université Paris-Saclay, Villejuif, France.

Alessia Ruggieri (A)

Department of Infectious Diseases, Molecular Virology, Centre for Integrative Infectious Disease Research (CIID), University of Heidelberg, Heidelberg, Germany.

Rachel Nechushtai (R)

The Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Jerusalem, Israel.

Etienne Morel (E)

Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH